Details for New Drug Application (NDA): 021908
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in AMITIZA is lubiprostone. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.
Summary for 021908
Tradename: | AMITIZA |
Applicant: | Sucampo Pharma Llc |
Ingredient: | lubiprostone |
Patents: | 9 |
Pharmacology for NDA: 021908
Mechanism of Action | Chloride Channel Activators |
Medical Subject Heading (MeSH) Categories for 021908
Suppliers and Packaging for NDA: 021908
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMITIZA | lubiprostone | CAPSULE;ORAL | 021908 | NDA AUTHORIZED GENERIC | Par Pharmaceutical Inc. | 0254-3028 | 0254-3028-02 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0254-3028-02) |
AMITIZA | lubiprostone | CAPSULE;ORAL | 021908 | NDA AUTHORIZED GENERIC | Par Pharmaceutical Inc. | 0254-3029 | 0254-3029-02 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0254-3029-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 24MCG | ||||
Approval Date: | Jan 31, 2006 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Dec 4, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD FOR TREATING OPIOID-INDUCED CONSTIPATION | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Aug 30, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMMALIAN SUBJECT | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Aug 30, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD FOR TREATING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED CONSTIPATION BY OPENING CIC CHANNELS |
Expired US Patents for NDA 021908
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription